Business Description
Immunic Inc
NAICS : 541714
SIC : 2834
ISIN : US92847R1041
Description
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 65.71 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 10.5 | |||||
| 3-Year EPS without NRI Growth Rate | 9.1 | |||||
| 3-Year FCF Growth Rate | 18.4 | |||||
| 3-Year Book Growth Rate | -56 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 34.1 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 73.67 | |||||
| 9-Day RSI | 60.91 | |||||
| 14-Day RSI | 52.64 | |||||
| 6-1 Month Momentum % | 6.5 | |||||
| 12-1 Month Momentum % | 11.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.71 | |||||
| Quick Ratio | 2.71 | |||||
| Cash Ratio | 2.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -28.7 | |||||
| Shareholder Yield % | 0.41 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -182.35 | |||||
| ROA % | -128.63 | |||||
| ROIC % | -2574.22 | |||||
| ROC (Joel Greenblatt) % | -5977.16 | |||||
| ROCE % | -178.74 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.71 | |||||
| Price-to-Tangible-Book | 2.7 | |||||
| EV-to-EBIT | -0.56 | |||||
| EV-to-EBITDA | -0.56 | |||||
| EV-to-FCF | -0.7 | |||||
| Price-to-Net-Current-Asset-Value | 2.82 | |||||
| Price-to-Net-Cash | 3.18 | |||||
| Earnings Yield (Greenblatt) % | -178.57 | |||||
| FCF Yield % | -68.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:IMUX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Immunic Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.23 | ||
| Beta | 1.87 | ||
| Volatility % | 61.77 | ||
| 14-Day RSI | 52.64 | ||
| 14-Day ATR ($) | 0.093064 | ||
| 20-Day SMA ($) | 1.149 | ||
| 12-1 Month Momentum % | 11.02 | ||
| 52-Week Range ($) | 0.97 - 2.11 | ||
| Shares Outstanding (Mil) | 90.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Immunic Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Immunic Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Immunic Inc Frequently Asked Questions
What is Immunic Inc(IMUX)'s stock price today?
The current price of IMUX is $1.24. The 52 week high of IMUX is $2.11 and 52 week low is $0.97.
When is next earnings date of Immunic Inc(IMUX)?
The next earnings date of Immunic Inc(IMUX) is 2025-02-21 Est..
Does Immunic Inc(IMUX) pay dividends? If so, how much?
Immunic Inc(IMUX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers